These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19998498)

  • 21. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
    Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
    J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?
    Zhang Z; Rosenbaum JT; Zhong W; Lim C; Hinrichs DJ
    Semin Immunopathol; 2010 Mar; 32(1):55-70. PubMed ID: 20119686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease.
    Kmieć Z; Cyman M; Ślebioda TJ
    Adv Med Sci; 2017 Mar; 62(1):1-16. PubMed ID: 28126697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-23/IL-17 axis in IBD.
    Sarra M; Pallone F; Macdonald TT; Monteleone G
    Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.
    Cao H; Diao J; Liu H; Liu S; Liu J; Yuan J; Lin J
    Inflamm Bowel Dis; 2023 May; 29(5):818-829. PubMed ID: 36166586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th17 cells: effector T cells with inflammatory properties.
    Korn T; Oukka M; Kuchroo V; Bettelli E
    Semin Immunol; 2007 Dec; 19(6):362-71. PubMed ID: 18035554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.
    Gomez-Bris R; Saez A; Herrero-Fernandez B; Rius C; Sanchez-Martinez H; Gonzalez-Granado JM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Li J; Yan Y; Meng Z; Liu S; Beck PL; Ghosh S; Qian J; Gui X
    Dig Dis Sci; 2017 Oct; 62(10):2755-2767. PubMed ID: 28597107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical model of the roles of T cells in inflammatory bowel disease.
    Lo WC; Arsenescu RI; Friedman A
    Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
    Pastorelli L; Garg RR; Hoang SB; Spina L; Mattioli B; Scarpa M; Fiocchi C; Vecchi M; Pizarro TT
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):8017-22. PubMed ID: 20385815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
    Dharmani P; Chadee K
    Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between effector Th17 and regulatory T cells.
    Awasthi A; Murugaiyan G; Kuchroo VK
    J Clin Immunol; 2008 Nov; 28(6):660-70. PubMed ID: 18810613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Th9 cells in inflammatory bowel diseases.
    Weigmann B; Neurath MF
    Semin Immunopathol; 2017 Jan; 39(1):89-95. PubMed ID: 27837255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation.
    Kanai T; Mikami Y; Sujino T; Hisamatsu T; Hibi T
    Mucosal Immunol; 2012 May; 5(3):240-7. PubMed ID: 22354322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines that regulate autoimmunity.
    Diveu C; McGeachy MJ; Cua DJ
    Curr Opin Immunol; 2008 Dec; 20(6):663-8. PubMed ID: 18834938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.